RoboCT UGO Exoskeleton 2025 (Medical)

BESCHREIBUNG

The UGO 2025 is the current generation of RoboCT's flagship rehabilitation exoskeleton for hospitals. Like the rest of the UGO line it is built on the principle of neuroplasticity: the machine drives the wearer through accurate walking training at high frequency and high repetition, on the argument that the nervous system relearns gait through correct repetition rather than effort alone. It is intended for patients whose lower limbs have been disabled by spinal cord injury, lower-limb myasthenia or other neurological conditions, and it lives in hospital rehabilitation departments and medical institutions where a therapist supervises the session. RoboCT publishes no dimensions or performance figures for it — what it publishes instead is the regulatory position, and that is the substantive claim: the UGO rehab exoskeletons are approved as China NMPA Class II medical devices and additionally hold US FDA registration and European CE certification.

FUNKTIONEN